GNH USA

Europe — EMA

Octaplex

GNH USA supplies Octaplex (Human Coagulation Factor IX), a coagulation factor replacement therapy for hemophilia B and related deficiencies.

Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Human Coagulation Factor IX (recombinant), the active ingredient in Octaplex, is a coagulation factor replacement therapy presented as a sterile solution for intravenous use. It is used to manage bleeding episodes and peri‑operative hemostasis in patients with hemophilia B and related factor deficiencies. GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?

Octaplex is a recombinant coagulation factor that acts within the intrinsic pathway of the clotting cascade to correct specific factor deficiencies.

- Hemophilia B: provides temporary replacement of factor IX to control and prevent bleeding. - Acquired factor IX deficiency: supplies the missing protein to restore normal clotting function. - Peri‑operative management: ensures adequate hemostasis during surgery for patients with factor IX deficiency.

What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Adverse reactions to Octaplex are generally related to its protein nature and the intravenous route of administration.

Common Side Effects: - Fever - Headache - Nausea - Mild infusion‑site erythema - Transient increase of ALT/AST

Serious or Rare Side Effects: - Anaphylactic reaction - Development of inhibitors (neutralising antibodies) to factor IX - Thromboembolic events - Severe hypersensitivity including serum sickness - Disseminated intravascular coagulation (DIA ).

What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Octaplex should be used only under the supervision of a qualified healthcare professional familiar with coagulation disorders.

- Dosing individualisation: adjust dose based on patient’s factor IX activity levels and clinical response. - Monitoring: regularly assess factor IX activity and watch for inhibitor development. - Contra‑indications: avoid in patients with known hypersensitivity to any component of the product. - Pregnancy and lactation: use only if clearly needed; benefits must outweigh risks. - Storage at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?

Octaplex may interact with other agents that affect hemostasis or immune response.

Major Interactions (Avoid): - Antifibrinolytics (e.g., tranexamic acid) combined with high‑dose factor IX may increase thrombosis risk. - Immune‑modulating therapies that could accelerate inhibitor formation.

Moderate Interactions (Monitor Closely): - Concomitant use of other clotting factor concentrates. - Concurrent anticoagulants (e.g., warfarin, direct oral anticoagulants) requiring careful monitoring of coagulation parameters. - Vaccines administered shortly before or after infusion may alter immune response. - Antibiotics such as beta‑lactams that can cause hypersensitivity reactions. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may increase bleeding tendency if factor levels are sub‑therapeutic.

Frequently asked questions

What is Octaplex used for?+
Octaplex is a recombinant human factor IX concentrate used to replace missing or deficient factor IX in patients with hemophilia B, acquired factor IX deficiency, or during surgery to provide adequate hemostasis.
How does Human Coagulation Factor IX work in Octaplex?+
The recombinant factor IX in Octaplex binds to activated factor X on platelet surfaces, forming the intrinsic tenase complex that accelerates conversion of prothrombin to thrombin, leading to fibrin clot formation and restored normal blood clotting.
What is the usual dose of Octaplex?+
The dose of Octaplex is individualized; a qualified prescriber determines the amount and frequency based on the patient’s factor IX activity level, weight, severity of bleeding and clinical situation.
Is Octaplex safe during pregnancy or breastfeeding?+
Octaplex may be used in pregnancy or lactation only when clearly needed. The prescriber must weigh potential benefits against risks, as limited data are available on fetal and infant exposure.
How do I order Octaplex from GNH USA?+
To order Octaplex, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.
How does Octaplex compare with other factor IX products?+
Octaplex is a recombinant, plasma‑free factor IX concentrate, offering a high purity profile and reduced risk of pathogen transmission compared with plasma‑derived products. Its pharmacokinetic profile is comparable to other recombinant factor IX products, but specific dosing and half‑life may differ.
What are the storage and handling requirements for Octaplex?+
Octaplex should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Before use, inspect the vial for particulate matter and ensure the solution is clear.
How is Octaplex administered?+
Octaplex is given by intravenous infusion. The rate and volume are determined by the prescriber, and the infusion set should be compatible with protein solutions to avoid adsorption.
What are the most serious risks associated with Octaplex?+
Serious risks include anaphylactic reactions, development of neutralising inhibitors to factor IX, thromboembolic events and disseminated intravascular coagulation. Immediate medical attention is required if any of these occur.
Who should not use Octaplex?+
Octaplex is contraindicated in individuals with known hypersensitivity to recombinant factor IX or any excipient in the formulation. It should also be avoided in patients with a history of severe inhibitor development unless under specialist supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F
Route
Intravenous Use
Manufacturer
Octapharma Ab
Origin
EU